Skip to main content

Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

IAS 2022

IAS 2022

  • Friday, April 22, 2022
  • 9:00 AM – 9:50 AM ET
    Challenging Case Scenarios
  • 10:05 AM – 10:50 AM ET
    Editors Focus - Best of 2021 Dermatology, Gastroenterology & Rheumatology
  • 11:05 AM – 12:05 PM ET
    Innovation Theater (non-accredited): Targeting Lupus Nephritis
  • 12:20 PM – 1:05 PM ET
    Disparities in Care in Immune Mediated Diseases
  • 1:20 PM – 2:05 PM ET
    Deep Dive: Combination Therapy Approaches
  • 1:20 PM – 2:05 PM ET
    Deep Dive: Wellness in the IMID patient population
  • 2:20 PM – 3:20 PM ET
    Innovation Theater (non-accredited): Taltz – An Overview of Efficacy and Safety in Plaque Psoriasis and Psoriatic Arthritis
  • 3:35 PM – 4:20 PM ET
    The Role of Interleukin Inhibitors in the Treatment of Moderate to Severe Psoriasis
  • 4:35 PM – 5:35 PM ET
    Innovation Theater (non-accredited): SAPHNELO™ (anifrolumab-fnia): The First-in Class Type 1 Interferon (IFN-1) Signaling Inhibitor
  • 5:50 PM – 6:35 PM ET
    Combined clinics - Combined Goals
  • 6:50 PM – 7:35 PM ET
    CAR-T Therapy for Autoimmune Diseases